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Background and Purpose: We hypothesized that the P-selectin (SELP) gene, localized
to a region on chromosome 1q24, pleiotropically contributes to increased blood pres-
sure and cerebral atrophy. We tested this hypothesis by performing genetic correlation
analyses for 13 mRNA gene expression measures from P-selectin and 11 other genes
located in 1q24 region and three magnetic resonance imaging derived indices of cere-
bral integrity. Methods: The subject pool consisted of 369 (219F; aged 28–85, aver-
age= 47.1± 12.7 years) normally aging, community-dwelling members of large extended
Mexican-American families. Genetic correlation analysis decomposed phenotypic correla-
tion coefﬁcients into genetic and environmental components among 13 leukocyte-based
mRNA gene expressions and three whole-brain and regional measurements of cerebral
integrity: cortical gray matter thickness, fractional anisotropy of cerebral white matter, and
the volume of hyperintensiveWM lesions. Results: From the 13 gene expressions, signif-
icant phenotypic correlations were only found for the P - and L-selectin expression levels.
Increases in P-selectin expression levels tracked with decline in cerebral integrity while the
opposite trend was observed for L-selectin expression. The correlations for the P-selectin
expression were driven by shared genetic factors, while the correlations with L-selectin
expression were due to shared environmental effects. Conclusion: This study demon-
strated that P-selectin expression shared a signiﬁcant variance with measurements of
cerebral integrity and posits elevated P-selectin expression levels as a potential risk factor
of hypertension-related cerebral atrophy.
Keywords: cerebral atrophy, genetics, DTI, aging, hypertension, gene expression, P-selectin
INTRODUCTION
Genetic factors are responsible for a large (40–80%) proportion
of individual variability in measurements of blood pressure (BP)
and cerebral integrity (Kochunov et al., 2009, 2010a;Winkler et al.,
2010). Elevated BP shares genetic risk factors with genetic risk fac-
tors for decline in cerebral integrity in both hypertensive (Turner
et al., 2005) and normally aging populations (DeStefano et al.,
2006; Kochunov et al., 2010b, 2011a). Some these risk factors were
localized to a region on the q-arm of chromosome one (1q24;
Turner et al., 2005; Kochunov et al., 2010b). This region was
also previously identiﬁed as harboring risk genes for develop-
ment of cardiovascular disorders (Blann et al., 2003; Zee et al.,
2004; Rutherford et al., 2007) and essential hypertension (Dug-
girala et al., 2000; Chang et al., 2007; Goring et al., 2007). Five
geneswithin this region, including a constellationof selectin (SELP,
SELL, and SELE) genes,ATP1B1 and the coagulation factorV (F5)
genes, were conﬁrmed to be involved in determining individual
susceptibility for essential hypertension (Kochunov et al., 2009,
2010a). Previously, we hypothesized that P-selectin (SELP) gene
was a likely contributor to the variations in BP and brain atrophy
BP (Kochunov et al., 2010b, 2011a). Elevated platelet P-selectin
expression level is a marker of endothelial dysfunction (Nomura
et al., 2009) and is positively correlated with systolic BP, pulse
pressure, and diagnosis of hypertension (Lee et al., 2008; Reiner
et al., 2008; Nomura et al., 2009). Common SELP sequence vari-
ants also explain a signiﬁcant proportion of individual variability
in the soluble P-selectin protein levels, even after correcting for
environmental factors such as smoking (Lee et al., 2008; Reiner
et al., 2008). Furthermore, SELP 1087A/G polymorphism is a
predictor of poorer neurocognitive functioning in hypertensive
elderly (Gunstad et al., 2009). Here, we aimed to test the hypothe-
sis that elevated P-selectin expression levels predict declining brain
integrity. To this end,we employed genetic correlations with quan-
titative mRNA expressions measured in large, extended pedigree
(Blangero et al., 2003). This approach has strategic beneﬁts such
as the increased power to study causal genes and increased power
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to detect the effects of rare functional variants, over the more
common strategy that has focused upon collections of unrelated
individuals (Blangero et al., 2003).
We performed these analyses using leukocyte-based mRNA
expression measurements for 12 genes the 1q24 region and
three magnetic resonance imaging (MRI)-derived measurements
of cerebral integrity in a well-characterized population of nor-
mally aging, community-dwelling Mexican-Americans from large
extended families (Mitchell et al., 1996). Gene expression mea-
surements were performed on the lymphocytes exacted from
blood samples collected 16 year prior to collection of imaging
data; hence, giving a prospective element to the brain mea-
sures. Previous analyses in this population established a positive
correlation between elevated expression levels for P-selectin and
arterial hypertension (Goring et al., 2007). Additional analyses
demonstrated a genetic relationship among BPmeasurements and
two MRI-derived measurements of cerebral white matter (WM)
integrity (Kochunov et al., 2010b, 2011a). Speciﬁcally, elevated
arterial pulse pressure and systolic BP corresponded to lower
fractional anisotropy (FA) of cerebral WM values (Kochunov
et al., 2011a). Elevated arterial pulse pressure and systolic BP
also corresponded to the increased volumes of subcortical and
ependymal hyperintensiveWM (HWM) regions (Kochunov et al.,
2010b), which is a classical marker of focal WM atrophy (Fazekas
et al., 1993). Here, we propose to test the next logical hypoth-
esis that there should be a signiﬁcant degree of shared genetic
variance between cerebral atrophy and gene expression level of
P-selectin and/or others genes located at the 1q24 QTL region. In
addition to two previously used measurements of WM atrophy,
we obtained whole-brain and regional measurements of cortical
gray matter (GM) thickness to estimate intersubject differences
in the integrity of cortical GM (Huttenlocher and Dabholkar,
1997).
MATERIALS AND METHODS
SUBJECTS
Three hundred sixty-nine (219 females) active participants in the
San Antonio Family Heart Study (SAFHS; Mitchell et al., 1996),
for whom gene expression and brain imaging data were avail-
able. They are Mexican-Americans from large extended families
selected randomly from the community. Subjects ranged from
28 to 85 years of age (47.1± 12.7 years) and were members of
47 families (9.3± 8.2 individuals/family; range 2–38). Subjects’
demographic and health information is detailed in Table 1. Four
hundred forty-eight SAFHS subjects, for whom transcript data
were available agreed to participate in the imaging study. Forty-six
subjects were excluded from the imaging for: MRI contraindica-
tions such as claustrophobia or presents of metal in their bodies
(N = 35), history of neurological illnesses, such as multiple scle-
rosis (N = 6), or stroke, transient ischemic attack or other major
neurological event (N = 5). Complete MRI data was not collected
for 33 subjects because a subject was unable to complete the MRI
session (N = 26), scannermalfunction (N = 4), and other reasons
(N = 3). All subjects provided written informed consent on forms
approved by the Institutional Review Board of the University of
Texas Health Science Center at San Antonio (UTHSCSA) and Yale
University.
MR imaging and data processing
Imaging data were collected using a Siemens 3 T Trio scanner
located at the Research Imaging Institute, UTHSCSA. The details
of imaging protocol and data collection are described elsewhere
(Kochunov et al., 2011b). In short, this study used a multimodal
MRI protocol speciﬁcally optimized for measurements of GM
thickness, FA values, and volume of HWM lesions.
The protocol for measurements of GM thickness was designed
to collect data capable of resolving the cortical ribbon across
Table 1 |Thirteen measurements of gene transcriptions were available for 12 genes located on chromos 1q24 between markers rs137915045 and
rs111909575.
Target ID* Accession number* Gene ID** Protein name Location** Length** Heritability (p)
GI_37595556-S NM_001677.2 ATP1B1 Sodium/potassium-transporting ATPase subunit
beta-1
169,075,947 26,014 0.315 (10−10)
GI_37574613-A NM_197972.1 NME7 Nucleoside diphosphate kinase 7 169,101,769 235,418 0.231 (10−6)
GI_37622354-S NM_003666.2 BLZF1 Basic leucine zipper nuclear factor 1 169,337,194 28,589 0.25 (10−10)
GI_27734718-S NM_006996.1 SLC19A2 Thiamine transporter 1 169,433,147 22,062 0.04 (10−3)
GI_10518500-S NM_000130.2 F5 Coagulation factor V 169,481,192 74,578 0.35 (10−10)
GI_6031196-S NM_003005.2 SELP P-selectin 169,558,087 41,291 0.34 (10−10)
GI_5713320-S NM_000655.2 SELL L-selectin 169,659,806 21,038 0.27 (10−10)
GI_15553096-S NM_033418.1 C1orf156 Histidine protein methyltransferase 1 homolog 169,761,670 2362 0.44 (10−10)
GI_40254930-S NM_018186.2 C1orf112 Uncharacterized protein C1orf112 169,764,550 57,680 0.20 (10−6)
GI_27363466-A NM_020423.4 SCYL3 Protein-associating with the carboxyl-terminal
domain of ezrin
169,821,804 41,273 0.40 (10−10)
GI_41281932-I NM_181093.1 SCYL3 Protein-associating with the carboxyl-terminal
domain of ezrin
169,821,804 41,273 0.12 (10−3)
GI_18105053-S NM_014970.2 KIFAP3 Kinesin-associated protein 3 169,890,470 153,410 0.32 (10−10)
GI_22748638-S NM_152281.1 GORAB RAB6-interacting golgin 170,501,263 21,712 0.25 (10−7)
*Illumina ID. **According to GRCh37.p2 primary reference assembly.
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the cerebral cortex using an isotropic spatial resolution of
0.8mm (voxel volume= 0.5mm3). T1-weighted contrast was
achieved using a magnetization prepared sequence with an
adiabatic inversion contrast-forming pulse (scan parameters:
TE/TR/TI= 3.04/2100/785ms, ﬂip angle= 11˚). A retrospective
motion correction technique (Kochunov et al., 2011b) was used
to reduce artifacts related to subject motion.Whole-brain average
and regional measurements of cortical thickness were performed
using a freely available BrainVisa software (Kochunov et al., 2012b;
Figure 1)1. This tool uses a “normal-average” algorithm that has
been reported to be a good compromise between accuracy andper-
formance (Lerch and Evans, 2005). The GM thickness is measured
as the Euclidean distance from an inner mesh vertex to the outer
mesh along the direction normal to the inner mesh polygon. The
measurement is repeated, inward, along the direction normal the
outer mesh and the two distances are averaged (Kochunov et al.,
2008). The consistency of the distance measurements is ensured
1http://www.nitrc.org/projects/brainvisa_ext/
by verifying that the line connecting the two surfaces does not
intersect other polygons, inner or outer, along the way. GM thick-
ness measurements were averaged for individual cortical areas for
both hemispheres; the whole-brain GM thickness measurement
was obtained by averaging all gyral GM thickness measurements
as described elsewhere (Wakana et al., 2004).
Diffusion tensor data were collected using a single-shot, echo-
planar, single refocusing spin-echo, T2-weighted sequence with
a spatial resolution of 1.7mm× 1.7mm× 3.0mm. The sequence
parameters were: TE/TR= 87/8000ms, FOV= 200mm, axial slice
orientation with 50 slices, and no gaps, 55 isotropically distrib-
uted diffusion weighted directions, two diffusion weighting values
(b = 0 and 700 s/mm2) and three b = 0 images. Details for the
choice of DTI parameters and processing of DTI scans, includ-
ing extracting whole-brain and regional FA values, are discussed
elsewhere (Kochunov et al., 2011b). In short, the tract-based spa-
tial statistics (TBSS) software (Kochunov et al., 2011b) was used
for multi-subject analysis of FA images. Whole-brain average FA
values were calculated by averaging values for the entireWMskele-
ton. Average FA values were calculated for nine major WM tracts
FIGURE 1 |T1-w image processing pipelines. AT1-w image is
skull-stripped, globally spatially normalized, and RF inhomogeneity
corrected (A). Next, cerebral hemispheres and cerebellum and identiﬁed
and tissue classiﬁed (B); cortical surfaces for GM and WM are calculated
(C,D) and homotopic erosion operation and crevasse detector are used to
reconstruct sulcal surface as the medial surface of the two opposing gyral
banks (E). Sulcal identiﬁcation pipeline uses a congregation of 500 artiﬁcial
neural network-based pattern classiﬁers to identify (F) sulcal landmarks
and to perform gyral segmentation of the cortex (G). GM thickness was
calculate as the distance between the pial (C) and GM/WM interface
surfaces (H). (I) Average GM thickness was calculated 14 primary cortical
gyri.
www.frontiersin.org May 2012 | Volume 3 | Article 65 | 3
Kochunov et al. P-selectin expression tracks cerebral atrophy
(Figure 2) as described elsewhere (Kochunov et al., 2010a, 2012a).
Brieﬂy, the population-based, 3D, DTI cerebral WM tract atlas
developed at the John Hopkins University (JHU) and distributed
as part of the FSL software package (Wakana et al., 2004) was used
to calculate population average diffusion parameter values along
the nine major WM tracts (Figure 2). The JHU atlas was non-
linearly aligned and labels for individual tracts were transferred to
the subjects’brains using nearest-neighbor interpolation. Per-tract
average values were calculated by averaging the values along the
tracts for both hemispheres. The overall average FA values were
calculated by averaging values for the entire WM skeleton.
Hyperintensive WM lesion data were collected using a
3D, T2-weighted imaging using a high-resolution (isotropic
1mm), turbo-spin-echo ﬂuid attenuated inversion recovery
(FLAIR) sequence with the following parameters: TR/TE/TI/Flip
angle/ETL= 5 s/353ms/1.8 s/180˚/221. FLAIR images were pre-
processed by removal of non-brain tissue, registration to the
Talairach frame and correction for RF inhomogeneity. HWM
regions were manually delineated in 3D-space using an in-
house software2 by an experienced neuroanatomist with high
(r2 > 0.9) test–retest reproducibility. HWM regions were coded
as ependymal regions, contiguous with CSF structures, and sub-
cortical in accordance with a technique described in (Henry
Feugeas et al., 2005). The WB-HWM volume and the volumes
of subcortical and ependymal HWM were measured for each
subject.
In addition towhole-brain averagemeasurements, regionalGM
thickness, FA values, andHWMvolumes was calculated for 14 cor-
tical areas, 10 major WM tracts and subcortical and ependymal
(periventricular) white, respective, using the parecelation method
described elsewhere (Kochunov et al., 2011b).
GENE EXPRESSION MEASUREMENTS
Thirteen gene expression transcripts were analyzed for 12 genes
located in a 2-Mb region of chromosome 1, between mark-
ers rs137915045 and rs111909575 (Turner et al., 2005; Chang
et al., 2007; Rutherford et al., 2007; Figure 3; Table 1). Gene
expression measures were derived from lymphocytes collected
16.6± 2.1 years prior to collection of imaging data. The details
of gene expression measurements are described by Goring et al.
(2007). In short, lymphocyte were obtained from blood samples
collected in themorning after an overnight fast. Lymphocytes were
isolated from a 10-ml sample using Histopaque (Sigma Chem-
ical Co.), following the suggested protocol of the manufacturer.
The isolated and washed lymphocytes were frozen and stored at
−80˚C overnight and then transferred into liquid nitrogen tanks.
Total RNAwas isolated from lymphocyte samples using amodiﬁed
procedure of the QIAGEN RNeasy 96 protocol for isolating total
RNA from animal cells using spin technology (QIAGEN, Inc.). Its
integrity was veriﬁed and anti-sense RNA was synthesized, ampli-
ﬁed, and puriﬁed. Hybridization of anti-sense RNA was carried
out using Illumina’s BeadChip 6× 2 protocol. Total isolated RNA
was hybridized to Illumina Sentrix HumanWhole Genome (WG-
6) Series 1 BeadChips as previously described (Goring et al., 2007).
2http://ric.uthscsa.edu/mango
These BeadChips simultaneously probes∼48,000 transcripts, rep-
resenting more than 25,000 annotated human genes. Processing
of the sample was performed in a single batch, thereby eliminating
the batch effect. Expression levels were z-normalized to make the
expression phenotypes comparable among individuals and across
transcripts (Goring et al., 2007). Finally, each transcript’s residual
expression scores were normalized by using an inverse Gaussian
transformation across individuals to ensure normality (Goring
et al., 2007).
STATISTICAL GENETIC ANALYSES
Variance components methods, as implemented in the Sequential
Oligogenic LinkageAnalysis Routines (SOLAR) software package3
(Almasy and Blangero, 1998), were used to estimate the degree of
shared genetic variability between gene expression measurements
and indexes of cerebral integrity. Brieﬂy, the covariance matrix Ω
for related individuals is given by Eq. 1
Ω = 2Φσ2g + Iσ
2
e (1)
where σ2g is the genetic variance due to residual additive genetic
factors, σ2e is the variance due to individual-speciﬁc environmen-
tal effects, and I is an identity matrix. Φ is the kinship matrix
that is assembled based on the family relationships and conﬁrmed
with molecular parent-offspring genetic testing. This matrix sum-
marizes the genetic relationships among all individuals. For addi-
tional explanation of the variance components approach using
in SOLAR (see Almasy and Blangero, 1998; Blangero et al., 2001).
Heritability (h2), the portion of the total phenotypic variance (σ2P)
that is accounted for by additive genetic variance (σ2g), is assessed
by contrasting the observed phenotypic covariance matrix with
the covariance matrix predicted by kinship (Eq. 2).
h2 = σ
2
g
σ2P
(2)
Bivariate genetic analysis calculates themagnitude and signiﬁcance
of phenotypic correlation coefﬁcient (ρP), and the proportion of
variability due to shared genetic (ρG) and environmental (ρE)
effects. The overall phenotypic correlation (ρP) between two traits
A and B (Eq. 3) can be expressed using the correlation due to
shared additive genetic effects (ρG) and the residual correlation
(ρE) due to shared environmental effects.
ρP =
√
h2A
√
h2B · ρG +
√
1 − h2A
√
1 − h2B · ρE (3)
Where, h2A and h
2
B denote the additive genetic heritability for each
of the traits, i.e., the proportion of the total phenotypic variance
that is explained by additive genetic factors. If the genetic cor-
relation coefﬁcient (ρG) is signiﬁcantly different from zero, then
the signiﬁcant portion of the variance in two traits are considered
to be inﬂuenced by shared genetic factors (Almasy et al., 1997).
All genetic analyses were conducted with age, sex, age∗sex, age2,
3http://solar.sfbrgenetics.org
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FIGURE 2 | Skeletonized, average FA values are shown on the population
average FA image.WM tract labels for nine major tracts are taken from the
Johns Hopkins DTI WM atlas. The average FA values were calculated for the
following tracts: corona radiata (CR), superior longitudinal fasciculus (SLF),
cingulate, external capsule (EC), internal capsule (IC), fronto-occipital (FO),
and the genu, body, and splenium of corpus callosum. The population-wise
average FA values are color coded on the skeleton of the tract. The location of
the axial slices (the Z -coordinate) is provided in theTalairach reference frame.
The three segment of Corpus Callosum are shown on the mid-sagittal slice
(Talairach X =0).
FIGURE 3 | Genes located under the QTL flanked rs137915045 and
rs111909575. Results (−log 10 of the p-value) of the correlation analysis for
expression levels for the genes located under the linkage peak are plotted
along the x -axis (bottom). The solid line corresponds to the signiﬁcant
evidence value of p =4×10−3. The green line corresponds to the suggestive
evidence value of p =0.05.
and age2∗sex included as covariates. The health screening data
as shown in Table 2, were not used as covariates because of the
loss of statistical power to detect genetic effects due to potential
overlap in risk factors. Including covariates that potentially share
both genetic and environmental variance may cause distortion
of ﬁndings in unknown ways. Tests for P-selectin transcripts and
cerebral integritymeasures were considered statistically signiﬁcant
at p < 0.05 based on the a priori hypothesis. Tests for correla-
tions with the other 12 transcripts were exploratory and only the
Bonferroni corrected p values were considered signiﬁcant. Sig-
niﬁcance of the bivariate genetic and environmental correlation
analysis was based on p < 0.05.
RESULTS
Genetic analyses reported statistically signiﬁcant phenotypic cor-
relation coefﬁcients (ρP) betweenmRNAexpressions forP-selectin
gene and all three measurements of cerebral integrity (Table 3). A
statistically signiﬁcant correlation (ρP) was also observed between
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L-selectin and FA values (p ≤ 0.004; Figure 3; Table 3). No sig-
niﬁcant correlations were observed for any other transcripts in
this region (Figure 3). A signiﬁcant genetic correlation (p ≤ 0.05)
was only observed between P-selectin expression levels and GM
thickness and FA values (Table 2). A signiﬁcant environmental
correlation (ρE;)(p ≤ 0.05)was observed between expression levels
for L-selectin and GM thickness and FA values.
Phenotypic correlation coefﬁcients between P-selectin expres-
sion and all regional GM thickness and FA measurements were
signiﬁcant (p ≤ 0.05)with exceptionof Sagittal Striatum(Table 4).
The sign of phenotypic correlations indicated that higher P-
selectin expressions were associated reduced GM thickness and
FA throughout the brain. Phenotypic correlation coefﬁcients were
signiﬁcant between L-selectin expression and six regional GM
thickness and for all regional FA measurements, with exception of
Splenium of Corpus Callosum (Table 4). These correlation coef-
ﬁcients were positive and driven by shared environmental factors
(Table 4). The correlation coefﬁcient for the L-selectin expres-
sions and subcortical HWM volumes was signiﬁcant (p = 0.01),
negative and driven by shared environmental factors (ρE =−0.25;
p = 0.05).
The correlation between the P- and L-selectin expressions were
not signiﬁcant ρP (p), ρG (p), and ρE (p)=−0.08 (0.12), 0.16
(0.60), and −0.22 (0.16), respectively.
DISCUSSION
This study aimed to identify genes, located on chromosome 1q24,
whose expression levels predicted brain atrophy in a population
of well-characterized Mexican-Americans. Previous research in
this population has demonstrated positive genetic relationships
between P-selectin expressions and arterial hypertension (Goring
et al., 2007) and between BP and pulse pressure andWM integrity
(DeStefano et al., 2006; Rutherford et al., 2007). Here, we demon-
strated that elevated mRNA expressions for P-selectin gene were
prospectively associated with reduced cerebral integrity and this
association was driven by shared genetic factors. In addition, we
observed a positive phenotypic correlation between the L-selectin
expression and cerebral FA values, which was driven by shared
environmental factors. The blood samples used in this study were
collected 16 years prior to the imaging assessments, minimizing
the potential that these traits were inﬂuenced by stress associated
with MR imaging (Tsankova et al., 2006). Overall, our ﬁnding
supported the hypothesis that P-selectin is the likely to be involved
in modulation of cerebral atrophy and that its mRNA expression
level is a promising peripheral biomarker of cerebral health.
P-selectin is a cell adhesion protein, expressed by endothelial
cells, that initiates adhesion to platelets and endothelial cells as
the part of the inﬂammatory reaction. Elevated levels of soluble
P-selectin protein in blood is a known risk factor for atheroscle-
rosis (Csongradi et al., 2011), essential hypertension (Zee et al.,
2004), cardiovascular disorders (Zakynthinos and Pappa, 2009),
and stroke (Zee et al., 2004; Preston et al., 2007). Platelet derived
P-selectin expression levels were shown to be positively correlated
with blood levels of soluble P-selectin protein (Csongradi et al.,
2011) and the diagnosis of the hypertension and atherosclerosis
(Lee et al., 2008; Reiner et al., 2008;Nomura et al., 2009). Common
SELP sequence variants, including rs2235302, rs6133, rs6136, and
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Table 3 | Results of the bivariate genetic correlation analysis included phenotypic (ρP), genetic (ρG), and environmental (ρE) correlation
coefficients and their significance (in parenthesis).
Target ID Gene ID Trait ρP (p) ρG (p) ρE (p)
SIGNIFICANTAT P ≤0.004
GI_6031196-S SELP GM thickness −0.21 (10−4) −0.68 (0.04) −0.10 (0.65)
GI_6031196-S SELP FA −0.19 (4·10−4) −0.50 (0.04) −0.05 (0.90)
GI_5713320-S SELL FA 0.18 (3·10−4) 0.01 (0.95) 0.27 (0.03)
SIGNIFICANTAT P ≤0.05
GI_5713320-S SELL HWM volume −0.12 (0.02) 0.02 (1) −0.25 (0.06)
GI_5713320-S SELL GM thickness 0.11 (0.04) 0.05 (0.95) 0.24 (0.04)
GI_6031196-S SELP HWM volume 0.12 (0.03) 0.19 (0.20) 0.21 (0.21)
Table 4 | Results of the bivariate genetic correlation analysis for regional measurement of cerebral integrity.
GI_6031196-S (SELP ) GI_5713320-S (SELL)
ρP (p); ρG (p); ρE (p) ρP (p); ρG (p); ρE (p)
REGIONAL CORTICAL GMTHICKNESS
Sup. frontal gyrus −0.19 (10−3); −0.55 (0.19); −0.09 (0.47) 0.12 (0.02); 0.69 (0.25); 0.26 (0.01)
Interm. frontal gyrus −0.16 (0.003); −0.55 (0.17); −0.05 (0.65) 0.10 (0.07); 0.74 (0.19); 0.25 (0.02)
Inf. frontal gyrus −0.17 (10−3); −0.56 (0.17); −0.07 (0.54) 0.09 (0.09); 0.68 (0.23); 0.23 (0.03)
Pre-central gyrus −0.18 (10−3); −0.56 (0.07); −0.03 (0.80) 0.09 (0.10); 0.60 (0.16); 0.27 (0.01)
Orbitofrontal cortex −0.17 (0.002); −0.44 (0.22); −0.08 (0.50) 0.10 (0.05); 0.85 (0.12); 0.26 (0.01)
Post-central gyrus −0.18 (10−4); −0.59 (0.05); −0.05 (0.70) 0.07 (0.22); 0.40 (0.33); 0.20 (0.09)
Superior parietal lobule −0.15 (0.004); −0.43 (0.19); −0.04 (0.75) 0.10 (0.05); 0.14 (0.73); 0.17 (0.13)
Inferior parietal lobule −0.18 (10−3); −0.46 (0.17); −0.08 (0.51) 0.09 (0.08); 0.18 (0.68); 0.16 (0.15)
S. temporal gyrus −0.20 (10−3); −0.47 (0.11); −0.08 (0.55) 0.08 (0.12); 0.39 (0.34); 0.21 (0.06)
Inf. and interm. temporal gyrus −0.19 (10−3); −0.43 (0.16); −0.09 (0.47) 0.10 (0.05); 0.27 (0.49); 0.21 (0.07)
Fusiform gyrus −0.17 (0.002); −0.35 (0.22); −0.08 (0.52) 0.07 (0.19); 0.58 (0.13); 0.24 (0.03)
Lateral occipital cortex −0.16 (0.003); −0.40 (0.17); −0.04 (0.75) 0.10 (0.05); 0.25 (0.48); 0.21 (0.07)
Medial occipital cortex −0.19 (10−3); −0.49 (0.12); −0.07 (0.62) 0.10 (0.06); −30 (0.48); 0.23 (0.05)
Cingulate gyrus −0.15 (0.005); −0.56 (0.16); −0.04 (0.76) 0.12 (0.02); 0.51 (0.36); 0.26 (0.02)
REGIONAL FA
Genu of corpus callosum −0.18 (0.002); −0.34 (0.09); 0.01 (0.96) 0.22 (10−5); 0.04 (0.90); 0.40 (0.01)
Body of corpus callosum −0.18 (10−3); −0.48 (0.03); 0.06 (0.69) 0.18 (10−4); −0.11 (0.70); 0.34 (0.01)
Splenium of corpus callosum −0.12 (0.03); −0.43 (0.07); 0.09 (0.56) 0.08 (0.13); 0.50 (0.29); 0.37 (0.01)
Cingulum −0.11 (0.03); −0.14 (0.62); −0.09 (0.56) 0.12 (0.02); 0.12 (0.71); 0.12 (0.38)
Corona radiata −0.14 (0.01); −0.13 (0.58); −0.14 (0.39) 0.17 (10−3); 0.15 (0.59); 0.18 (0.21)
External capsule −0.17 (10−3); −0.12 (0.68); −0.23 (0.23) 0.17 (10−3); 0.32 (0.37); 0.11 (0.40)
Internal capsule (including thalamic radiation) −0.12 (0.05); −0.17 (0.52); −0.09 (0.55) 0.14 (0.01); 0.21 (0.60); 0.11 (0.51)
Superior/inferior fronto-occipital fasciculi −0.15 (0.005); −0.05 (0.83); −0.21 (0.14) 0.14 (0.01); 0.22 (0.45); 0.11 (0.37)
Superior longitudinal fasciculus −0.13 (0.02); −0.15 (0.51); −0.11 (0.51) 0.17 (0.002); 0.24 (0.39); 0.13 (0.38)
Sagittal stratum −0.08 (0.09); −0.32 (0.21); 0.06 (0.68) 0.12 (0.02); 0.34 (0.26); 0.02 (0.87)
REGIONAL HWMVOLUMES
Subcortical 0.07 (0.10); 0.27 (0.10); 0.28 (0.10) −0.14 (0.01); 0.08 (0.79); −0.25 (0.05)
Periventricular 0.06 (0.25); 0.02 (0.95); 0.05 (0.75) −0.06 (0.26); 0.15 (0.62); −0.17 (0.24)
rs3917854, were demonstrated to explain a signiﬁcant (5–13%)
portion of individual variability in soluble P-selectin measured
in plasma (Lee et al., 2008; Reiner et al., 2008). Our ﬁnding of
signiﬁcant negative correlation between P-selectin expression and
cerebral integrity also replicates anobservation in the Framingham
heart study subjects where the blood level of P-selectin protein
were negatively correlated with the brain volume (Preston et al.,
2007). Further analyses, involving deep sequencing and functional
variants will be necessary for the true identiﬁcation of the spe-
ciﬁc polymorphisms that are associated with increased cerebral
atrophy.
Signiﬁcant phenotypic correlation was observed between L-
selectin (SELL) expressions and FA of cerebral WM. The direc-
tion of the correlation indicated that increased L-selectin expres-
sion levels corresponded to higher FA values. The signiﬁcance
of the environmental correlation coefﬁcient (ρE) suggested that
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this relationship was driven by shared environmental factors. L-
selectin protein has both adhesive and signaling functions and
its physiological role is different from that of P-selectin (Shigeta
et al., 2008). The L-selectin levels do not increased during essential
hypertension (Sanada et al., 2005) and do not predict develop-
ment of vascular inﬂammation during vascular encephalomyelitis
(Doring et al., 2007). Experiments in lab animals demonstrate
that P-selectin expression is signiﬁcantly up-regulated in inﬂamed
CNS microvessels but no signiﬁcant change was observed for L-
selectin expression (Doring et al., 2007). Instead, L-selectin levels
were shown to be essential for leukocytes’ recruitment into CNS
in response to bacterial meningitis (Sulik et al., 2006), sepsis, and
viral brain infections (Sulik et al., 2006) and were predictive of
increased survival rates in patients with acute brain injury (Bri-
assoulis et al., 2007). Additionally, L-selectin participates in the
in vitro attachment of lymphocytes toWM with its ligand located
on the actual myelin sheaths of CNS neurons (Huang et al., 1994).
The shiverer mouse, which lacks compact myelin, has a greatly
diminished density of L-selectin ligands (Huang et al., 1994). The
positive relationship between the expression levels of L-selectin
and FA values may, therefore, reﬂect upon the anti-inﬂammatory
role of this gene in maintaining homeostasis of the cerebral WM.
This is the ﬁrst study to empirically demonstrate the utility
of lymphocyte-based P-selectin expression level measurements for
a study of cerebral integrity phenotypes. Expression levels of P-
selectin gene in the cerebral endothelial cells would be the ideal
trait for this study. However, the impracticality of obtaining such
measurements in large, genetically informative samples necessi-
tates the use of a surrogate marker. On the other hand, P-selectin
is highly expressed in human lymphocytes4 and P-selectin pro-
tein is critically involved in the migration of lymphocytes into
brain tissue during ischemic stroke injury (Marquardt et al.,
2009; Yilmaz and Granger, 2010) and modulation of cerebral
inﬂammation in multiple sclerosis (Piccio et al., 2005; Engelhardt,
2008). Additionally, other expression levels in lymphocytes have
already been demonstrated to be good surrogates for gene expres-
sion in several neurological and psychiatric disease-relevant genes
(Borovecki et al., 2005; Tsuang et al., 2005; Glahn et al., 2012). For
instance, the lymphocyte-based expressions ranked higher than
any of the behavioral or neurocognitive assessment measurement
for marking the risk of major depressive disorder, suggesting that
lymphocyte-based transcriptional proﬁles is an important marker
for psychiatric disease risks (Glahn et al., 2012).
Weobserved no signiﬁcant correlations betweenmeasurements
of cerebral integrity and expression levels for two other, ATP1B1
and F5, genes whose polymorphism were implicated as potential
4http://www.genecards.org/cgi-bin/carddisp.pl?gene=SELP#expression
risk factors for essential hypertensionBP inCaucasians (Kochunov
et al., 2009). This could be due to ethnic differences as this study
was focused onMexican-Americans, a population with signiﬁcant
Native American admixture. Mexican-Americans are character-
ized by a higher rate of metabolic syndrome when compared with
non-Hispanic whites in San Antonio (Mitchell et al., 1996). Ele-
vated P-selectin expression levels are also observed in atherosclero-
sis,diabetes,obesity, and coronary artery disease (Zakynthinos and
Pappa, 2009; Csongradi et al., 2011) and our ﬁndings may not be
speciﬁc to hypertension, other than in the sense that hypertension
is part of themetabolic syndrome. Therefore, the lack of ﬁnding of
a signiﬁcant correlation for ATP1B1 and F5 expression levels can-
not be interpreted as conclusive evidence against the hypothesis
that this relationship does not exists nor does it conﬁrm the lack
of the overall pleiotropic relationship.
CONCLUSION
Our ﬁndings in a cohort of normally aging, community-dwelling,
Mexican-Americans demonstrated that P-selectin is likely candi-
date, responsible for the bivariate QTL between measures of BP
and cerebral integrity in the 1q24 region. Our analyses demon-
strated that P-selectin expression levels explained 3–4% of the
variability in the measurements of cerebral integrity. This is
smaller than the predictive power of BP measurements on cere-
bral integrity (10–20%; Kochunov et al., 2011a). However, it is
similar to the prospective predictive power (∼5%) of the serum P-
selectin levels on the intersubject variability in the carotid intima–
media thickness measured 5 years later. Our ﬁndings also support
the hypothesis of a direct genetic relationship between P-selectin
expression and cerebral atrophy as proposed by two studies that
demonstrated neurocognitive differences in the elderly carriers
of 1087 allele of this gene (Mathew et al., 2007; Gunstad et al.,
2009). However, allele-speciﬁc PCR validation will be necessary
to name the speciﬁc genetic variants that are responsible for this
association. Additional research is also needed to clarify if the lack
of genetic association for the ATP1B1 and F5 genes, previously
reported in Caucasians, may be due to ethnic differences in the
Mexican-American population studied here.
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